Discovery DMPK Services
Pharmaron’s DMPK services support the needs for preclinical candidate (PCC) identification and nomination, Investigational New Drug (IND) enabling and New Drug Application (NDA) packaging for regulatory submission.
Pharmaron’s DMPK group offers comprehensive in vitro ADME, in vitro toxicity and in vivo pharmacokinetics services, which allow for the evaluation of DMPK properties and toxicity of test articles with high data quality and in a cost-effective manner.
in vivo PK
- Screening PK
- Tissue distribution
- Metabolism and excretion
- in vivo PK models
- Endogenous biomarkers
in vitro ADMET
- Solution properties
- Drug absorption and transport
- Metabolic stability and metabolite identification
- Drug-drug interactions
- in vitro Toxicity
DMPK Studies for R&D Efficiency
Learn how Pharmaron helps our partners improve their drug R&D efficiency.